|
HY-120166-10mg
|
MedChemexpress LLC
|
DiFMu P [CAS 214491-43-7]
|
|
|
|
|
HY-120166-100mg
|
MedChemexpress LLC
|
DiFMu P [CAS 214491-43-7]
|
|
|
|
|
HY-120166-25mg
|
MedChemexpress LLC
|
DiFMu P [CAS 214491-43-7]
|
|
|
|
|
HY-120166-5mg
|
MedChemexpress LLC
|
DiFMu P [CAS 214491-43-7]
|
|
|
|
|
HY-120166-50mg
|
MedChemexpress LLC
|
DiFMu P [CAS 214491-43-7]
|
|
|
|
|
HY-130767A-100mg
|
MedChemexpress LLC
|
Naphthol AS-TR phosphate (disodium) [CAS 4264-93-1]
|
|
|
|
|
HY-138589-10mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dG [CAS 666847-77-4]
|
|
COVID-19-anti-virus
|
|
|
HY-138589-100mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dG [CAS 666847-77-4]
|
|
COVID-19-anti-virus
|
|
|
HY-138589-5mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dG [CAS 666847-77-4]
|
|
COVID-19-anti-virus
|
|
|
HY-138589-50mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dG [CAS 666847-77-4]
|
|
COVID-19-anti-virus
|
|
|
HY-138590-10mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-100mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-25mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-5mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-50mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-153335-10mg
|
MedChemexpress LLC
|
Enpp-1-IN-16 [CAS 2289739-47-3]
|
|
|
|
|
HY-153335-100mg
|
MedChemexpress LLC
|
Enpp-1-IN-16 [CAS 2289739-47-3]
|
|
|
|
|
HY-153335-25mg
|
MedChemexpress LLC
|
Enpp-1-IN-16 [CAS 2289739-47-3]
|
|
|
|
|
HY-153335-5mg
|
MedChemexpress LLC
|
Enpp-1-IN-16 [CAS 2289739-47-3]
|
|
|
|
|
HY-153335-50mg
|
MedChemexpress LLC
|
Enpp-1-IN-16 [CAS 2289739-47-3]
|
|
|
|
|
HY-P1309-1mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1309-10mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1309-5mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1309A-1mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide (TFA) [CAS 1228078-65-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1309A-10mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide (TFA) [CAS 1228078-65-6]
|
|
COVID-19-immunoregulation
|
|
